You are here
The rule, which was made effective immediately, would assign less weight to studies built on medical histories and other confidential data from human subjects where the underlying information was not revealed. That sort of research — including dose-response studies, which evaluate how much a person’s exposure to a substance increases the risk of harm — have been used for decades to justify EPA regulations.
Trump officials, including then-EPA administrator Andrew Wheeler, argued that the new rule would provide the public with greater insight into the scientific basis for new regulations.
But critics argued that the Trump administration aimed to impede or block access to the best available science, weakening the government’s ability to create new protections against pollution, pesticides, and possibly even the coronavirus. ...
Recent Comments